Baudax Bio Stock Shares Outstanding
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
Baudax Bio fundamentals help investors to digest information that contributes to Baudax Bio's financial success or failures. It also enables traders to predict the movement of Baudax Stock. The fundamental analysis module provides a way to measure Baudax Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Baudax Bio stock.
Baudax |
Baudax Bio Company Shares Outstanding Analysis
Baudax Bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Baudax Bio Shares Outstanding | 43.59 M |
Most of Baudax Bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Baudax Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Baudax Bio has 43.59 M of shares currently outstending. This is 75.85% lower than that of the Biotechnology sector and 59.2% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.38% higher than that of the company.
Baudax Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Baudax Bio's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Baudax Bio could also be used in its relative valuation, which is a method of valuing Baudax Bio by comparing valuation metrics of similar companies.Baudax Bio is currently under evaluation in shares outstanding category among its peers.
Baudax Fundamentals
| Return On Equity | -47.04 | |||
| Return On Asset | -1.15 | |||
| Operating Margin | (27.60) % | |||
| Current Valuation | 17.72 M | |||
| Shares Outstanding | 43.59 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 2.68 % | |||
| Number Of Shares Shorted | 493.56 K | |||
| Price To Earning | 0.03 X | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 0.75 X | |||
| Revenue | 1.27 M | |||
| Gross Profit | (5.74 M) | |||
| EBITDA | (34.76 M) | |||
| Net Income | (7.15 M) | |||
| Cash And Equivalents | 5.65 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 7.12 M | |||
| Debt To Equity | 2.26 % | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.84) X | |||
| Cash Flow From Operations | (14.31 M) | |||
| Short Ratio | 0.19 X | |||
| Earnings Per Share | (94.13) X | |||
| Target Price | 24.0 | |||
| Beta | 1.58 | |||
| Market Capitalization | 950.33 K | |||
| Total Asset | 10.03 M | |||
| Retained Earnings | (190.9 M) | |||
| Working Capital | (15.11 M) | |||
| Current Asset | 21.72 M | |||
| Current Liabilities | 7.92 M | |||
| Net Asset | 10.03 M |
About Baudax Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baudax Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baudax Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baudax Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |